Sharemaestro Newsreel

Intuitive Surgical to Demonstrate Telerobotic Surgery Live at SRS

Intuitive Surgical will conduct a live telerobotic surgery demonstration at the Society of Robotic Surgery (SRS) meeting, connecting surgeons in California and Georgia. The demonstration will use the da Vinci 5 system to showcase remote collaboration and shared-control capabilities on an advanced tissue model. …

Intuitive Surgical Stock Is On Sale, But Is The Growth Story Changing?

Intuitive Surgical (ISRG) stock has dropped 23% from its recent high due to a slowdown in U.S. robotic procedure growth, despite strong demand for its new da Vinci 5 systems and robust international growth. This presents a critical juncture for investors, prompting questions about …

Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India

Aravind Eye Care System and Alcon have launched a Global Centre of Excellence (CoE) for Vitreoretinal Surgery Training in Coimbatore, India. This new CoE is the second phase of their partnership, following a Global Cataract Centre of Excellence launched in 2024, aiming to address …

Aptargroup Inc (ATR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Aptargroup Inc (ATR) has an earnings forecast score of 8.75, ranking it first in the Containers & Packaging industry. The average price target for ATR is $154.00, with analysts predominantly recommending a "Buy" trend. The company's expected revenue for the next quarter is $1.01 …

Align Technology stock trades lower after softer Q1 2026 revenue and cautious outlook

Align Technology's stock fell after reporting softer-than-expected Q1 2026 revenue of $1.0 billion and a 17% decline in diluted earnings per share to $1.50, missing analyst consensus. The company issued a cautious full-year 2026 outlook, projecting mid-single-digit revenue growth and continued margin pressure, despite …

Kaplan Fox Reminds Investors of Embecta Corp. (NASDAQ: EMBC) to a Securities Class Action Deadline - Contact the Firm Before August 17, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Embecta Corp. (NASDAQ: EMBC) for investors who purchased securities between November 25, 2025, and May 4, 2026. This action follows Embecta's disappointing Q2 2026 financial results and reduced fiscal 2026 revenue guidance, …

Baxter stock trades steadily as spin-off and transformation reshape earnings profile

Baxter International is undergoing a significant transition, reshaping its earnings profile through the spin-off of its Renal Care and Acute Therapies businesses into Vantive. While this restructuring led to lower revenue in fiscal 2023, the company maintained stable adjusted EPS and improved operating margins …

Baxter International Inc. Revenue Breakdown – NYSE:BAX

This article provides a detailed revenue breakdown for Baxter International Inc (BAX) by business segment and geographical region. As of April 6 (updated), the company's largest business segments are Infusion Therapies and Technologies and Care and Connectivity Solutions, while the United States accounts for …

Zacks.com featured highlights include AIM ImmunoTech, Hasbro, Fox, Cencora and Intuitive Surgical

For Immediate Release Chicago, IL – July 24, 2026 – Stocks in this week's article are AIM ImmunoTech AIM, Hasbro HAS, Fox FOX, Cencora Inc. COR and Intuitive Surgical ISRG. Bet on 5 Top-Ranked Stocks with Rising P/E Ratios Investors often opt for the …

ATR|Aptargroup Inc|Price:133.095|Chg%:-2.325

AptarGroup, Inc. is a company that designs and manufactures drug and consumer product dosing, dispensing, and protection technologies, serving pharmaceutical, beauty, food, beverage, personal care, and home care markets. The article provides an overview of the company, its financial details, and its executive team. …

Utah Medical Products Releases Q2 2026 Financial Results

Utah Medical Products, Inc. reported weaker second-quarter results for Q2 2026, with diluted earnings of $0.84 per share on revenue of $8.5M. This represents a decline from the prior year, attributed to headwinds across its business segments. The company, specializing in niche medical devices, …

Align Technology Inc (ALGN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Align Technology Inc (ALGN) has an earnings forecast score of 7.79, ranking 122nd in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $175.00, with current ratings showing a consensus to "Buy" based on 19 analysts. The company's expected …

ALGN|Align Technology Inc|Price:168.270|Chg%:-4.190

Align Technology Inc. (ALGN) is a global medical device company known for its Invisalign system of clear aligners and iTero intraoral scanners. The company's financials include a market cap of $11.97 billion and a P/E TTM of 28.00. Institutional holdings show 1683 institutions collectively …

3 Promising Penny Stocks With Market Caps Over $60M

This article identifies three promising penny stocks—OraSure Technologies (OSUR), Castellum (CTM), and Protalix BioTherapeutics (PLX)—each with market caps over $60M. It highlights their financial health, recent achievements, and growth prospects, noting that while some are currently unprofitable, they exhibit strong balance sheets and strategic …

STVN|Stevanato Group SpA|Price:19.390|Chg%:+0.020

Stevanato Group SpA (STVN) is experiencing healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Healthcare Equipment & Supplies industry. The stock is rated as a "Buy" by multiple analysts, with a target price of 25.175, indicating a significant …

How Solventum Corporation When-issued (SOLV) Affects Rotational Strategy Timing

This article analyzes Solventum Corporation When-issued (SOLV) using AI models to provide trading strategies. It highlights a weak near-term sentiment with a mid-channel oscillation, presenting a significant risk-reward setup. The analysis includes position, momentum, and risk-hedging strategies, along with multi-timeframe signal analysis for different …

Harvard Bioscience Inc (HBIO) Financial Health: Profitability & Balance Sheet Analysis

Harvard Bioscience Inc (HBIO) currently holds a financial score of 7.07, ranking 113 out of 200 in the Healthcare Equipment & Supplies industry, indicating a weak financial status but high operating efficiency. The company's latest quarterly revenue decreased by 4.68% year-over-year to $20.75 million, …

Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-and-stock deal

Repligen is acquiring BioLife Solutions (BLFS) in a cash-and-stock deal valued at approximately $1.5 billion, with BioLife shareholders receiving $11.25 cash and 0.1442 Repligen shares per BioLife share. The acquisition aims to strengthen Repligen's position in the rapidly growing cell therapy market, leveraging BioLife's …

Femasys Inc (FEMY) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Femasys Inc (FEMY), highlighting its current market data and score on TradingKey. As of July 24, 2026, the company's valuation score is 8.97, placing it 54th in the Healthcare Equipment & Supplies industry, with a P/E ratio …

Sei Investments Co. Has $132.65 Million Stake in West Pharmaceutical Services, Inc. $WST

Sei Investments Co. has a significant stake worth $132.65 million in West Pharmaceutical Services, Inc., despite trimming its holdings by 10.6% in the first quarter. The medical instruments supplier has shown strong financial performance, beating Q2 expectations with EPS of $2.37 and revenue of …

First Trust Advisors LP Acquires 57,931 Shares of LeMaitre Vascular, Inc. $LMAT

First Trust Advisors LP increased its stake in LeMaitre Vascular (NASDAQ:LMAT) by 6.2% during the first quarter, now holding 998,071 shares valued at $108.96 million. Other institutional investors also adjusted their positions in the company, while insiders have sold shares totaling over $5.9 million …

CooperCompanies stock trades steadily as contact lens growth supports earnings

CooperCompanies' stock remains stable, driven by increased revenue from its CooperVision (contact lenses) and CooperSurgical (women's health) divisions. The company's fiscal 2025 results show a 7% year-over-year revenue growth to $3.1 billion, with robust operating margins and strong cash flow supporting ongoing investment and …

Intuitive Surgical Inc (ISRG) turnover swells as weekly loss hits 15.1%

The robotic-surgery maker’s setback has pushed the 12-week return deeper into negative territory, with trend support still absent.

West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For

West Pharmaceutical Services (WST) is set to announce its Q2 earnings before market open tomorrow. Analysts are anticipating a 9.9% year-on-year revenue growth, aligning with estimates that have remained stable over the last 30 days. The healthcare products company is coming off a strong …

POCI Q2 2026 Earnings: Narrow Loss Reported, Shares Dip Nearly 5% - Energy Earnings Report

Nyxoah (NYXH) Q1 2026 Earnings: Narrowed Loss Beats Estimates, Shares Dip 4.76% - Earnings Deceleration Risk

OSUR Q1 2026 Earnings: EPS Misses Estimates by a Wide Margin; Stock Rises Despite Loss - Profit Recovery Report

HBIO Q1 2026 Earnings: Surprise EPS Beat Despite Negative Stock Reaction - Revenue Growth Outlook

Daxor Corporation (DXR) Holds Steady Near Support in Tight Trading Range - High Volume Stocks

West Pharmaceutical Delivers Another Beat - But The Real Story Is The Mix Shift (NYSE:WST)

ZTEK Q3 2023 Earnings: Narrower-Than-Expected Loss Drives Stock Higher - Analyst Drop Coverage

Nyxoah (NYXH) Q1 2026 Earnings: EPS Beat Narrowes Losses, Shares Dip as Market Awaits Revenue Milestones

Nyxoah (NYXH) Q1 2026 Earnings: Narrowed Loss Beats Estimates, Shares Dip 4.76% - Earnings Sentiment Score

West Pharmaceutical Earnings: Another Strong Quarter and Upward Guidance Revision

What is HC Wainwright's Estimate for BLFS Q1 Earnings?

Avantor, Inc. (AVTR) Stock forecasts

Argus provides a report on Avantor, Inc. (AVTR), a provider of products and services to customers in various industries, including biopharma and healthcare. The report includes an earnings estimate rating and a current price of $11.44 for AVTR stock. The article encourages users to …